PRME 241220 7.50P (PRME241220P7500) Stock Options, News & Quotes

US OptionsDetailed Quotes

PRME241220P7500

Watchlist

0.00
0.000.00%

15min DelayClose Dec 20 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

We Think Prime Medicine (NASDAQ:PRME) Needs To Drive Business Growth Carefully
Simply Wall StDec 19 07:35 ET
Express News | Prime Medicine Inc Files for Resale of up to 11 Mln Common Shares by the Selling Stockholder - SEC Filing
ReutersDec 13 08:20 ET
JMP Securities Initiates Prime Medicine at Market Outperform With $10 Price Target
MT NewswiresDec 10 07:28 ET · Ratings
JMP Securities Initiates Prime Medicine(PRME.US) With Buy Rating, Announces Target Price $10
Moomoo NewsDec 10 01:31 ET · Ratings
Prime Medicine, Inc.: Innovative Gene Editing Platform With Significant Market Potential
TipRanksDec 10 01:06 ET
Express News | Guggenheim Reiterates Buy on Prime Medicine, Maintains $18 Price Target
BenzingaDec 3 11:44 ET

Comments

Trytosaveabit

Nov 22 19:02

New 13D/A

$Prime Medicine (PRME.US)$ Prime Medicine | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-ARCH Venture Fund X, L.P.(11.8%),ARCH Venture Fund X Overage, L.P.(11.8%), etc.
SEC· 17:36

This_Guy

Nov 11 09:59

$Prime Medicine (PRME.US)$ 👀

Jaguar8

Oct 24 07:02

NEWS

$Prime Medicine (PRME.US)$
Prime Medicine Presents In Vivo Proof-of-Concept Data Highlighting Interim Preclinical Advances in its Wilson’s Disease Program and the Broad Potential of its Universal Liver-Targeted LNP at ESGCT 31st Annual Congress

Cheok

Sep 30 09:09

$Prime Medicine (PRME.US)$ Break $5!

Jaguar8

Sep 30 08:48

For me this is the biggest news for the day. Great collab with huge milestones

$Prime Medicine (PRME.US)$